MyCare - Patients: View your medical records securely online here.
Log in Learn More

SWOG S1207 – Phase III Randomized, Placebo – Controlled Clinical Trial Evaluating the use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High – Rick, Hormone Receptor – Positive and Her2 / Neu Negative Breast Cancer.” “ e³ Breast Cancer Study – evaluating everolimus with endocrine therapy.”

IRB Number: SWOG S1207
Start Date: February 10, 2014
Principal Name: Peter Bushunow, MD
Contact Name: Denise Maracle, RN
Phone: (585) 747-4555
Alternative Phone: (585) 922-9146